Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.47 |
| ▸ | MEN1 | O00255 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.46 |
| ▸ | GSR | P00390 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | RAB9A | P51151 | 3/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 7/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6812083 | 0.88 | POLB (0.54) | KMT2AMEN1ALDH1A1TDP1POLB | |
| SCHEMBL6812085 | 0.88 | POLB (0.54) | KMT2AMEN1ALDH1A1TDP1POLB | |
| SCHEMBL7004850 | 0.83 | PTGS2 (0.55) | KMT2AMEN1ALDH1A1HDAC1HDAC8 | |
| SCHEMBL7004841 | 0.83 | PTGS2 (0.55) | KMT2AMEN1ALDH1A1HDAC1HDAC8 | |
| SCHEMBL30390592 | 0.82 | HDAC1 (0.65) | KMT2AMEN1ALDH1A1TDP1HDAC1 | |
| SCHEMBL1569438 | 0.82 | HDAC1 (0.65) | KMT2AMEN1ALDH1A1TDP1HDAC1 | |
| SCHEMBL1569435 | 0.82 | HDAC1 (0.65) | KMT2AMEN1ALDH1A1TDP1HDAC1 | |
| SCHEMBL6821922 | 0.80 | HDAC1 (0.45) | KMT2AMEN1ALDH1A1TDP1HDAC1 | |
| SCHEMBL6821923 | 0.80 | HDAC1 (0.45) | KMT2AMEN1ALDH1A1TDP1HDAC1 | |
| SCHEMBL6913160 | 0.79 | NPC1 (0.47) | KMT2AMEN1ALDH1A1HDAC1HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6689899-B2 | HYDROGENATION OF THE CORRESPONDING DINITRO COMPOUNDS | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2004-02-10 | — | — | US | disclosed |
| US-20020019558-A1 | Diamine and acid anhydride | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2002-02-14 | — | — | US | disclosed |
| US-6303742-B1 | CHARACTERIZED BY A CINNAMOYL GROUP OR A DERIVED CINNAMOYL GROUP INCORPORATED THEREIN AND BY PHOTO-REACTIVITY AND HEAT-REACTIVITY WHICH ARE INHERENT IN THE CINNAMOYL GROUP. | KANEKAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2001-10-16 | — | — | US | disclosed |
| EP-0659796-B1 | Liquid crystalline polyesters | NIPPON OIL CO LTD (JP) | 1999-03-17 | — | — | EP | disclosed |
| US-5432249-A | Liquid crystalline polyesters | NIPPON OIL COMPANY, LIMITED (JP) | 1995-07-11 | — | — | US | disclosed |
| EP-0659796-A2 | Liquid crystalline polyesters | NIPPON OIL COMPANY, LIMITED (JP) | 1995-06-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020019558-A1 | Diamine and acid anhydride | CA1, ASIC1, CA4 | KMT2A 679/4885MEN1 1404/4885ALDH1A1 116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.